For individuals facing Transthyretin Amyloid Cardiomyopathy (ATTR-CM), a serious condition, the emergence of Tafamidis and Tafamidis meglumine represents a genuine advancement . These groundbreaking therapies preserve the transthyretin protein, preventing its damaging build-up and reducing the severity of the disease . Patients are now seeing po… Read More